Anna E Ek1, Sophia M Rössner, Emilia Hagman, Claude Marcus. 1. Division of Pediatrics, National Childhood Obesity Centre, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Abstract
OBJECTIVE: In this cohort of severely obese children and adolescents in Sweden we investigate the prevalence of impaired fasting glucose (IFG), impaired glucose tolerance, (IGT) and silent type 2 diabetes (T2D), in relation to insulin resistance, insulin secretion, disposition index and cardio respiratory fitness. METHODS: A total of 134 obese children and adolescents [57 females, 77 males, age 13.7 ± 2.7, body mass index (BMI) standard deviation score (SDS) 3.6 ± 0.6] consecutively referred to the National Childhood Obesity Centre performed an oral glucose tolerance test (OGTT), frequently sampled intravenous glucose tolerance test (fs-IVGTT), dual X-ray absorptiometry (DEXA), bicycle ergometer test and fasting levels of glucose, insulin and c-peptide were obtained and homeostatic model of insulin resistance (HOMA-IR) was calculated. RESULTS: Isolated impaired fasting glucose (i-IFG) were present in 35.8 and 6% had isolated IGT. Combined IGT and IFG were present in 14.2%. The subjects with combined IGT/IFG had significantly lower acute insulin response (AIR) compared with subjects who had normal glucose metabolism or i-IFG (p < 0.05). Among the prepubertal children (n = 24), 25% (6/24) had i-IFG and 25% (6/24) had IGT/IFG and it was predominantly males. Disposition index was the major determinant of 2-h glucose levels (β = -0.49, p = 0.0126). No silent diabetes was detected. CONCLUSION: In this cohort of severely obese children and adolescents the prevalence of prediabetes was very high. IFG was two times higher in this cohort of severely obese children than in a recently published unselected cohort of obese children in Sweden. In spite of the high prevalence of prediabetes, no subjects with silent diabetes were found.
OBJECTIVE: In this cohort of severely obesechildren and adolescents in Sweden we investigate the prevalence of impaired fasting glucose (IFG), impaired glucose tolerance, (IGT) and silent type 2 diabetes (T2D), in relation to insulin resistance, insulin secretion, disposition index and cardio respiratory fitness. METHODS: A total of 134 obesechildren and adolescents [57 females, 77 males, age 13.7 ± 2.7, body mass index (BMI) standard deviation score (SDS) 3.6 ± 0.6] consecutively referred to the National Childhood Obesity Centre performed an oral glucose tolerance test (OGTT), frequently sampled intravenous glucose tolerance test (fs-IVGTT), dual X-ray absorptiometry (DEXA), bicycle ergometer test and fasting levels of glucose, insulin and c-peptide were obtained and homeostatic model of insulin resistance (HOMA-IR) was calculated. RESULTS: Isolated impaired fasting glucose (i-IFG) were present in 35.8 and 6% had isolated IGT. Combined IGT and IFG were present in 14.2%. The subjects with combined IGT/IFG had significantly lower acute insulin response (AIR) compared with subjects who had normal glucose metabolism or i-IFG (p < 0.05). Among the prepubertal children (n = 24), 25% (6/24) had i-IFG and 25% (6/24) had IGT/IFG and it was predominantly males. Disposition index was the major determinant of 2-h glucose levels (β = -0.49, p = 0.0126). No silent diabetes was detected. CONCLUSION: In this cohort of severely obesechildren and adolescents the prevalence of prediabetes was very high. IFG was two times higher in this cohort of severely obesechildren than in a recently published unselected cohort of obesechildren in Sweden. In spite of the high prevalence of prediabetes, no subjects with silent diabetes were found.
Authors: P Di Bonito; L Pacifico; C Chiesa; G Valerio; E Miraglia Del Giudice; C Maffeis; A Morandi; C Invitti; M R Licenziati; S Loche; G Tornese; F Franco; M Manco; M G Baroni Journal: J Endocrinol Invest Date: 2016-11-16 Impact factor: 4.256
Authors: P Di Bonito; M R Licenziati; D Corica; M G Wasniewska; A Di Sessa; E Miraglia Del Giudice; A Morandi; C Maffeis; M F Faienza; E Mozzillo; V Calcaterra; F Franco; G Maltoni; G Valerio Journal: J Endocrinol Invest Date: 2022-05-17 Impact factor: 5.467
Authors: Iris Ciba; Loretta S Warnakulasuriya; Adikaram V N Adikaram; Peter Bergsten; Marie Dahlbom; Manel M A Fernando; Elisabet Rytter; Dulani L Samaranayake; K D Renuka Ruchira Silva; V Pujitha Wickramasinghe; Anders H Forslund Journal: Pediatr Diabetes Date: 2020-11-04 Impact factor: 3.409